Clores, Mark .

HRN: 29-46-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2026
CEFUROXIME 1.5GM (VIAL)
08/12/2026
08/19/2026
IV
450MG
Q8H
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines